Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer’s disease transgenic mouse model

Código QR

Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer’s disease transgenic mouse model

Abstract Alzheimer’s disease (AD) is a devastating neurodegenerative disorder with no disease-modifying treatment. AD progression is characterized by cognitive decline, neuroinflammation, and accumulation of amyloid-beta (Aβ) and neurofibrillary tangles in the brain, leading to neuronal and glial dy...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jackie K. Y. Lau, Min Tian, Yang Shen, Shun-Fat Lau, Wing-Yu Fu, Amy K. Y. Fu, Nancy Y. Ip
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/5e145d10ba444c13a408a1dd72b67715
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Mitochondrial ubiquitin ligase alleviates Alzheimer’s disease pathology via blocking the toxic amyloid-β oligomer generation
por: Keisuke Takeda, et al.
Publicado: (2021)

Ethanol Alleviates Amyloid-β-Induced Toxicity in an Alzheimer’s Disease Model of Caenorhabiditis elegans
por: Shuju Bai, et al.
Publicado: (2021)

Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder
por: Cai Z, et al.
Publicado: (2013)

CSF VEGF Was Positively Associated with Neurogranin Independent of β-Amyloid Pathology
por: Huang Y, et al.
Publicado: (2020)

Trilobatin Alleviates Cognitive Deficits and Pathologies in an Alzheimer’s Disease Mouse Model
por: Jiuyang Ding, et al.
Publicado: (2021)

Intravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic mice.
por: Eric A Tanifum, et al.
Publicado: (2012)

Robust light–dark patterns and reduced amyloid load in an Alzheimer’s disease transgenic mouse model
por: Rohan Nagare, et al.
Publicado: (2020)

Aminostyrylbenzofuran directly reduces oligomeric amyloid-β and reverses cognitive deficits in Alzheimer transgenic mice.
por: Sang-Hyun Lee, et al.
Publicado: (2014)

Quinacrine directly dissociates amyloid plaques in the brain of 5XFAD transgenic mouse model of Alzheimer’s disease
por: Sohui Park, et al.
Publicado: (2021)

Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic mice.
por: Nikisha Carty, et al.
Publicado: (2013)

Inhibition of MALT1 Alleviates Spinal Ischemia/Reperfusion Injury-Induced Neuroinflammation by Modulating Glial Endoplasmic Reticulum Stress in Rats
por: Zhang S, et al.
Publicado: (2021)

Topmouth culter melanocortin-3 receptor: regulation by two isoforms of melanocortin-2 receptor accessory protein 2
por: Ren-Lei Ji, et al.
Publicado: (2021)

ER-associated degradation regulates Alzheimer’s amyloid pathology and memory function by modulating γ-secretase activity
por: Bing Zhu, et al.
Publicado: (2017)

TDP-43 interacts with amyloid-β, inhibits fibrillization, and worsens pathology in a model of Alzheimer’s disease
por: Yao-Hsiang Shih, et al.
Publicado: (2020)

The neuritic plaque facilitates pathological conversion of tau in an Alzheimer’s disease mouse model
por: Tong Li, et al.
Publicado: (2016)

Pharmacological modulation of the cAMP signaling of two isoforms of melanocortin-3 receptor by melanocortin receptor accessory proteins in the tetrapod Xenopus laevis
por: Ying Xu, et al.
Publicado: (2021)

The role of melanocortin 1 receptor on melanogenesis pathway in skin color differentiation of red tilapia
por: Lan-mei Wang, et al.
Publicado: (2022)

Effects of melanocortin 1 receptor agonists in experimental nephropathies.
por: Annika Lindskog Jonsson, et al.
Publicado: (2014)

Glial and endothelial blood-retinal barrier responses to amyloid-&beta; in the neural retina of the rat
por: Peter JB Anderson, et al.
Publicado: (2008)

Machine Learning to Predict Brain Amyloid Pathology in Pre-dementia Alzheimer’s Disease Using QEEG Features and Genetic Algorithm Heuristic
por: Nam Heon Kim, et al.
Publicado: (2021)

Polymorphic structures of Alzheimer's β-amyloid globulomers.
por: Xiang Yu, et al.
Publicado: (2011)

Minimally invasive biomarker confirms glial activation present in Alzheimer&#39;s disease: a preliminary study
por: Tran T, et al.
Publicado: (2011)

Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer’s disease
por: Sang Su Kwak, et al.
Publicado: (2020)

A modified formulation of Huanglian-Jie-Du-Tang reduces memory impairments and β-amyloid plaques in a triple transgenic mouse model of Alzheimer’s disease
por: Siva Sundara Kumar Durairajan, et al.
Publicado: (2017)

Peganum harmala enhanced GLP-1 and restored insulin signaling to alleviate AlCl3-induced Alzheimer-like pathology model
por: Rofida A. Saleh, et al.
Publicado: (2021)

Divergent effects of central melanocortin signalling on fat and sucrose preference in humans
por: Agatha A. van der Klaauw, et al.
Publicado: (2016)

The Role of Melanocortin Plasticity in Pain-Related Outcomes After Alcohol Exposure
por: Nathan Sharfman, et al.
Publicado: (2021)

Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer’s Disease-Related Pathology in APP/PS-1 Mice
por: Kong L, et al.
Publicado: (2020)

Effects of far infrared light on Alzheimer's disease-transgenic mice.
por: Koji Fukui, et al.
Publicado: (2021)

Functional variants of the melanocortin-4 receptor associated with the Odontoceti and Mysticeti suborders of cetaceans
por: Liyuan Zhao, et al.
Publicado: (2017)

Traumatic brain injury in the presence of Aβ pathology affects neuronal survival, glial activation and autophagy
por: Linn Streubel-Gallasch, et al.
Publicado: (2021)

Non-coding variability at the APOE locus contributes to the Alzheimer’s risk
por: Xiaopu Zhou, et al.
Publicado: (2019)

Oligodendrocytes damage in Alzheimer's disease: Beta amyloid toxicity and inflammation
por: ROTH,ALEJANDRO D, et al.
Publicado: (2005)

Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies
por: Tao Yang, et al.
Publicado: (2020)

In situ identification and G4-PPI-His-Mal-dendrimer-induced reduction of early-stage amyloid aggregates in Alzheimer’s disease transgenic mice using synchrotron-based infrared imaging
por: Núria Benseny-Cases, et al.
Publicado: (2021)

Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer’s Disease Related Pathology and Cognitive Decline
por: Shan Liu, et al.
Publicado: (2017)

Association of APOE e2 genotype with Alzheimer’s and non-Alzheimer’s neurodegenerative pathologies
por: Terry E. Goldberg, et al.
Publicado: (2020)

Identification of new EphA4 inhibitors by virtual screening of FDA-approved drugs
por: Shuo Gu, et al.
Publicado: (2018)

Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta.
por: Nicole Schonrock, et al.
Publicado: (2010)

Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease.
por: Michael Bartl, et al.
Publicado: (2021)